PL352331A1 - Pharmaceutical compositions containing ciprofloxacyne and method of obtaining same - Google Patents
Pharmaceutical compositions containing ciprofloxacyne and method of obtaining sameInfo
- Publication number
- PL352331A1 PL352331A1 PL00352331A PL35233100A PL352331A1 PL 352331 A1 PL352331 A1 PL 352331A1 PL 00352331 A PL00352331 A PL 00352331A PL 35233100 A PL35233100 A PL 35233100A PL 352331 A1 PL352331 A1 PL 352331A1
- Authority
- PL
- Poland
- Prior art keywords
- weight
- ciprofloxacyne
- ciprofloxacin
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 5
- 229960003405 ciprofloxacin Drugs 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229920002774 Maltodextrin Polymers 0.000 abstract 1
- 239000005913 Maltodextrin Substances 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 229940035034 maltodextrin Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902725A HU227070B1 (en) | 1999-08-11 | 1999-08-11 | Immediate release pharmaceutical composition containing ciprofloxacin and process for its production |
| PCT/HU2000/000090 WO2001012162A1 (en) | 1999-08-11 | 2000-08-11 | Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL352331A1 true PL352331A1 (en) | 2003-08-11 |
Family
ID=89999030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00352331A PL352331A1 (en) | 1999-08-11 | 2000-08-11 | Pharmaceutical compositions containing ciprofloxacyne and method of obtaining same |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1207857B1 (cs) |
| AT (1) | ATE241967T1 (cs) |
| AU (1) | AU6716100A (cs) |
| BG (1) | BG106404A (cs) |
| CZ (1) | CZ2002505A3 (cs) |
| DE (1) | DE60003196T2 (cs) |
| HK (1) | HK1046234B (cs) |
| HU (1) | HU227070B1 (cs) |
| PL (1) | PL352331A1 (cs) |
| RU (1) | RU2251420C2 (cs) |
| SK (1) | SK285236B6 (cs) |
| UA (1) | UA72270C2 (cs) |
| WO (1) | WO2001012162A1 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
| WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
| DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| EP1880722B1 (en) * | 2006-07-19 | 2010-03-17 | Tabuk Pharmaceutical Manufacturing Co. | Pharmaceutical compositions of ciprofloxacin |
| CN107669645A (zh) * | 2017-10-31 | 2018-02-09 | 瑞阳制药有限公司 | 盐酸环丙沙星片的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3601566A1 (de) * | 1986-01-21 | 1987-07-23 | Bayer Ag | Pharmazeutische zubereitungen von ciprofloxacin |
| US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| AU3691297A (en) * | 1996-08-15 | 1998-03-06 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
-
1999
- 1999-08-11 HU HU9902725A patent/HU227070B1/hu not_active IP Right Cessation
-
2000
- 2000-08-11 AU AU67161/00A patent/AU6716100A/en not_active Abandoned
- 2000-08-11 DE DE60003196T patent/DE60003196T2/de not_active Expired - Fee Related
- 2000-08-11 WO PCT/HU2000/000090 patent/WO2001012162A1/en not_active Ceased
- 2000-08-11 EP EP00954808A patent/EP1207857B1/en not_active Expired - Lifetime
- 2000-08-11 PL PL00352331A patent/PL352331A1/xx unknown
- 2000-08-11 RU RU2002106727/15A patent/RU2251420C2/ru not_active IP Right Cessation
- 2000-08-11 CZ CZ2002505A patent/CZ2002505A3/cs unknown
- 2000-08-11 SK SK213-2002A patent/SK285236B6/sk unknown
- 2000-08-11 AT AT00954808T patent/ATE241967T1/de not_active IP Right Cessation
- 2000-08-11 HK HK02105791.8A patent/HK1046234B/en not_active IP Right Cessation
- 2000-11-08 UA UA2002031867A patent/UA72270C2/uk unknown
-
2002
- 2002-02-01 BG BG06404A patent/BG106404A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002106727A (ru) | 2004-01-10 |
| BG106404A (bg) | 2002-09-30 |
| HUP9902725A2 (hu) | 2001-12-28 |
| DE60003196T2 (de) | 2004-04-29 |
| EP1207857A1 (en) | 2002-05-29 |
| EP1207857B1 (en) | 2003-06-04 |
| HU227070B1 (en) | 2010-06-28 |
| ATE241967T1 (de) | 2003-06-15 |
| SK285236B6 (sk) | 2006-09-07 |
| AU6716100A (en) | 2001-03-13 |
| SK2132002A3 (en) | 2002-08-06 |
| HU9902725D0 (en) | 1999-10-28 |
| RU2251420C2 (ru) | 2005-05-10 |
| WO2001012162A1 (en) | 2001-02-22 |
| UA72270C2 (en) | 2005-02-15 |
| DE60003196D1 (de) | 2003-07-10 |
| CZ2002505A3 (cs) | 2002-06-12 |
| HK1046234A1 (en) | 2003-01-03 |
| HK1046234B (en) | 2004-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007048219A3 (en) | Sustained drug release composition | |
| MY157790A (en) | Trazodone composition for once a day administration | |
| IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
| BR0012046A (pt) | Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória | |
| MY125651A (en) | Eplerenone compositions | |
| MX9505182A (es) | Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p. | |
| AU6750996A (en) | Oral fast-dissolving compositions for dopamine agonists | |
| WO2004012699A3 (en) | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent | |
| DZ2549A1 (fr) | Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan. | |
| HUP0003842A1 (hu) | Készítmény mü-opioidvegyületek által okozott légzési depresszió és a kísérő mellékhatások csökkentésére | |
| CY2469B1 (en) | Pharmaceutical compositions for sustained release of the hmg-coa reductase inhibitor fluvastatin. | |
| WO2003080070A3 (en) | Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| TR200301723T4 (tr) | 1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı | |
| TR199700878T1 (xx) | Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar. | |
| NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
| CA2378428A1 (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
| GB2364641A (en) | Stabilized oral pharmaceutical composition containing iodide and iodate and method | |
| CA2325739A1 (en) | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator | |
| DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
| PL352331A1 (en) | Pharmaceutical compositions containing ciprofloxacyne and method of obtaining same | |
| WO2000056345A3 (en) | Methods for limiting scar and adhesion formation | |
| NZ523606A (en) | Pharmaceutical compositions and methods for use | |
| AR021158A2 (es) | Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina | |
| AU2003286210A1 (en) | Smoke composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |